Case Report: Spironolactone Withdrawal Associated With a Dramatic Response in a Patient With Metastatic Castrate-Resistant Prostate Cancer. Clin Genitourin Cancer 2017 Feb;15(1):e95-e97
Date
09/20/2016Pubmed ID
27641657DOI
10.1016/j.clgc.2016.08.006Scopus ID
2-s2.0-84994708562 (requires institutional sign-in at Scopus site) 9 CitationsAuthor List
Flynn T, Guancial EA, Kilari M, Kilari DAuthor
Deepak Kilari MD Associate Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Abiraterone AcetateBenzamides
Drug Antagonism
Humans
Male
Middle Aged
Neoplasm Metastasis
Nitriles
Phenylthiohydantoin
Prostatic Neoplasms, Castration-Resistant
Spironolactone
Treatment Outcome